These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 16195820)
41. Psychosocial correlates of pregnant women's attitudes toward prenatal maternal serum screening and invasive diagnostic testing: beyond traditional risk status. Lumley MA; Zamerowski ST; Jackson L; Dukes K; Sullivan L Genet Test; 2006; 10(2):131-8. PubMed ID: 16792517 [TBL] [Abstract][Full Text] [Related]
42. Psycho-social aspects of breast cancer susceptibility testing: a literature review. Brédart A; Autier P; Audisio RA; Geragthy J Eur J Cancer Care (Engl); 1998 Sep; 7(3):174-80. PubMed ID: 9793009 [TBL] [Abstract][Full Text] [Related]
43. Health locus of control and perceived risk for breast cancer in healthy women. Rowe JL; Montgomery GH; Duberstein PR; Bovbjerg DH Behav Med; 2005; 31(1):33-40. PubMed ID: 16078524 [TBL] [Abstract][Full Text] [Related]
44. Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations. Khabele D; Runowicz CD Curr Womens Health Rep; 2002 Jun; 2(3):163-9. PubMed ID: 12099190 [TBL] [Abstract][Full Text] [Related]
45. Awareness of genetic testing for breast cancer risk among women with a family history of breast cancer: effect of women's information sources on their awareness. Meischke H; Bowen D; Kuniyuki A Cancer Detect Prev; 2001; 25(4):319-27. PubMed ID: 11531008 [TBL] [Abstract][Full Text] [Related]
46. Psychosocial issues associated with increased breast and ovarian cancer risk: findings from focus groups. Pasacreta JV Arch Psychiatr Nurs; 1999 Jun; 13(3):127-36. PubMed ID: 10389341 [TBL] [Abstract][Full Text] [Related]
47. Consumer knowledge and opinions of genetic testing for breast cancer risk. Vuckovic N; Harris EL; Valanis B; Stewart B Am J Obstet Gynecol; 2003 Oct; 189(4 Suppl):S48-53. PubMed ID: 14586321 [TBL] [Abstract][Full Text] [Related]
48. Evaluation of a shared decision making program for women suspected to have a genetic predisposition to breast cancer: preliminary results. Stalmeier PF; Unic IJ; Verhoef LC; Van Daal WA Med Decis Making; 1999; 19(3):230-41. PubMed ID: 10424830 [TBL] [Abstract][Full Text] [Related]
49. Coping with genetic testing for breast cancer susceptibility. Dougall AL; Smith AW; Somers TJ; Posluszny DM; Rubinstein WS; Baum A Psychosom Med; 2009 Jan; 71(1):98-105. PubMed ID: 19124622 [TBL] [Abstract][Full Text] [Related]
50. Hereditary breast cancer. Psychosocial issues and family physicians' role. Carroll JC; Heisey RE; Warner E; Goel V; McCready DR Can Fam Physician; 1999 Jan; 45():126-32. PubMed ID: 10889865 [TBL] [Abstract][Full Text] [Related]
51. Women's perceptions of breast cancer risk: how you ask matters. Woloshin S; Schwartz LM; Black WC; Welch HG Med Decis Making; 1999; 19(3):221-9. PubMed ID: 10424829 [TBL] [Abstract][Full Text] [Related]
52. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress. van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788 [TBL] [Abstract][Full Text] [Related]
53. Women's views on chemoprevention of breast cancer: qualitative study. Heisey R; Pimlott N; Clemons M; Cummings S; Drummond N Can Fam Physician; 2006 May; 52(5):624-5. PubMed ID: 17327893 [TBL] [Abstract][Full Text] [Related]
54. Using the common sense model to understand perceived cancer risk in individuals testing for BRCA1/2 mutations. Kelly K; Leventhal H; Andrykowski M; Toppmeyer D; Much J; Dermody J; Marvin M; Baran J; Schwalb M Psychooncology; 2005 Jan; 14(1):34-48. PubMed ID: 15386791 [TBL] [Abstract][Full Text] [Related]
55. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer. Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771 [TBL] [Abstract][Full Text] [Related]
56. Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families. Katapodi MC; Northouse LL; Milliron KJ; Liu G; Merajver SD Psychooncology; 2013 Jun; 22(6):1336-43. PubMed ID: 22826208 [TBL] [Abstract][Full Text] [Related]
57. Diagnosed with breast cancer while on a family history screening programme: an exploratory qualitative study. Clements A; Henderson BJ; Tyndel S; Evans G; Brain K; Austoker J; Watson E; Eur J Cancer Care (Engl); 2008 May; 17(3):245-52. PubMed ID: 18419627 [TBL] [Abstract][Full Text] [Related]
58. Attitudes and psychological impact of genetic testing, genetic counseling, and breast cancer risk assessment among women at increased risk. Hutson SP Oncol Nurs Forum; 2003; 30(2):241-6. PubMed ID: 12692658 [TBL] [Abstract][Full Text] [Related]
59. Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: women's looking back on the pre-test period and a psychological evaluation. Claes E; Evers-Kiebooms G; Boogaerts A; Decruyenaere M; Denayer L; Legius E Genet Test; 2004; 8(1):13-21. PubMed ID: 15140370 [TBL] [Abstract][Full Text] [Related]
60. A community based study on intentions regarding predictive testing for hereditary breast cancer. Welkenhuysen M; Evers-Kiebooms G; Decruyenaere M; Claes E; Denayer L J Med Genet; 2001 Aug; 38(8):540-7. PubMed ID: 11494966 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]